Evolutec Ltd FY Pretax Loss Widens; Priority to Explore Strategic Options
2/27/2007 2:12:36 PM
More...
|
Evolutec Ltd To Stop Investing In rEV131 As Fails To Meet Trial Primary Endpoint
1/3/2007 6:35:10 PM
More...
|
Evolutec Ltd Release: Primary Endpoint Not Met In Phase IIb rEV131 Trial In Allergic Rhinitis
12/4/2006 5:57:41 PM
More...
|
Evolutec Ltd Release: Phase II Post-Cataract Eye Inflammation Trial Is Fully Recruited
11/17/2006 2:47:59 PM
More...
|
Evolutec Ltd Release: Commencement Of Phase II Trial In The Treatment Of Inflammation Following Cataract Surgery
6/20/2006 5:23:47 PM
More...
|
Evolutec Ltd Gets Positive Pre-clinical Data On Lead Molecule
2/28/2006 2:18:52 PM
More...
|
Evolutec Ltd Announces £10 Million Fundraising
10/19/2005 5:13:21 PM
More...
|
Evolutec Ltd Finds Better Reception, Raises £9.5M In Private Round
10/19/2005 5:13:10 PM
More...
|
Cyclacel Postpones Dual Listing; Evolutec Gets Less Than Sought
10/19/2005 5:11:21 PM
More...
|
Evolutec Ltd Announces Positive Phase II Clinical Result For rEV131 In Seasonal Allergic RHiNITIS
10/19/2005 5:08:52 PM
More...
|
|